StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI – Get Rating) from a sell rating to a hold rating in a research note published on Monday.

Several other equities research analysts also recently commented on ICUI. KeyCorp reduced their target price on shares of ICU Medical from $230.00 to $225.00 in a research note on Tuesday, August 9th. TheStreet cut ICU Medical from a b- rating to a c rating in a report on Wednesday, May 11th. Finally, Raymond James cut their price target on ICU Medical from $208.00 to $190.00 and set an outperform rating for the company in a report on Tuesday, August 9th.

ICU Medical Trading Up 1.9 %

Shares of ICU Medical stock opened at $168.50 on Monday. The company's fifty day simple moving average is $168.49 and its 200-day simple moving average is $191.80. The company has a market cap of $4.03 billion, a price-to-earnings ratio of 401.20 and a beta of 0.57. The company has a current ratio of 2.45, a quick ratio of 1.25 and a debt-to-equity ratio of 0.78. ICU Medical has a 1 year low of $154.73 and a 1 year high of $259.93.

Hedge Funds Weigh In On ICU Medical

Several institutional investors and hedge funds have recently modified their holdings of the business. Verition Fund Management LLC grew its position in shares of ICU Medical by 402.8% in the 2nd quarter. Verition Fund Management LLC now owns 6,385 shares of the medical instruments supplier's stock valued at $1,050,000 after purchasing an additional 5,115 shares during the period. Legal & General Group Plc grew its position in shares of ICU Medical by 2.5% in the 2nd quarter. Legal & General Group Plc now owns 48,331 shares of the medical instruments supplier's stock valued at $7,945,000 after purchasing an additional 1,158 shares during the period. Macquarie Group Ltd. grew its position in shares of ICU Medical by 23.5% in the 2nd quarter. Macquarie Group Ltd. now owns 800 shares of the medical instruments supplier's stock valued at $132,000 after purchasing an additional 152 shares during the period. Captrust Financial Advisors grew its position in shares of ICU Medical by 4.5% in the 2nd quarter. Captrust Financial Advisors now owns 1,327 shares of the medical instruments supplier's stock valued at $218,000 after purchasing an additional 57 shares during the period. Finally, Tamarack Advisers LP acquired a new position in shares of ICU Medical in the 2nd quarter valued at approximately $2,137,000. 90.20% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

(Get Rating)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.

Further Reading

• Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
• Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
• Are These Green Energy Companies Right For Your Portfolio?
• When Will the Hangover Finally Be Over for Seagate Technology?
• Does Enphase Energy Have the Juice to Keep Powering Higher?
• The One Hydrogen Fuel Cell Stock To Rule Them All

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.